Clinical Studies
Clinical studies on our Solution for Scars formulation showed visible improvement in the appearance of scars in as little as two weeks*.
Summary Of Our Clinical Trial
A Double-Blind, Randomised Trial Shows the Role of Zonal Priming and Direct Topical Application of Solution for Scars topical in the Reduction of Cutaneous Scarring in Human Skin.
increase in
hydration
improvement in
elasticity of scar
increase in the presence
of antioxidants
*62 people took part in a controlled double blind clinical study on recently healed scars. A Double-Blind, Randomised Trial shows the Role of Zonal Priming and Direct Topica Application of Epigallocatechin-3-Gallate in the Modulation of Cutaneous Scarring in Human Skin Sara Ud-Din, Phillip Foden, Mohsin Mazhari, Samer AL-Habba, Mohamed Baguneid, Silvia Bulfons-Paus, Douglas McGeorge and Ardeshir Bayat.
The results of these trials, while confidential to protect proprietary information, have been reviewed and is peer reviewed and published in the American journal of Investigative Dermatology (JID)
The results from Ex Vivo Evaluation of Topical Skin Formulations Using an Optimised Skin Organ Culture Model, can be found below.